These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8785976)

  • 21. Steps towards the development of a replacement in vitro test for quantification of antibodies to tetanus toxin during potency testing of vaccine.
    Southern J; Clements H; Spenceley L
    Dev Biol Stand; 1996; 86():343. PubMed ID: 8785983
    [No Abstract]   [Full Text] [Related]  

  • 22. [Determination of tetanus antitoxin using passive hemagglutination test: a comparison between tannic acid and BDB methods].
    Kameyama S; Hoda S; Nagaoka F; Kondo R
    Rinsho Byori; 1974 Oct; 22(10 Suppl):186. PubMed ID: 4475787
    [No Abstract]   [Full Text] [Related]  

  • 23. The use of an immunoenzymatic assay for the estimation of tetanus antitoxin in human sera: a comparison with seroneutralization and indirect haemagglutination.
    Gentili G; Pini C; Collotti C
    J Biol Stand; 1985 Jan; 13(1):53-9. PubMed ID: 3988779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of rocket immuno-electrophoresis (RIE) and ELISA for determination of tetanus antibodies in tetanus immunoglobulins.
    Zott A
    Dev Biol Stand; 1996; 86():348. PubMed ID: 8785988
    [No Abstract]   [Full Text] [Related]  

  • 25. [Duration of immunity after administration of heterologous and homologous tetanus antitoxin and its enzymatical disintegration (author's transl)].
    Krasemann C; Schneider W
    Z Immunitatsforsch Exp Klin Immunol; 1972 Jan; 143(1):59-75. PubMed ID: 4282907
    [No Abstract]   [Full Text] [Related]  

  • 26. Measurement of tetanus antitoxin. II. Toxin neutralization.
    Peel MM
    J Biol Stand; 1980; 8(3):191-207. PubMed ID: 7410443
    [No Abstract]   [Full Text] [Related]  

  • 27. A serological potency assay for Clostridium chauvoei.
    Hauer PJ; Whitaker MS; Henry LA
    Dev Biol Stand; 1996; 86():331. PubMed ID: 8785971
    [No Abstract]   [Full Text] [Related]  

  • 28. Tetanus prophylaxis. Experimental assay in horses, with penicillin and tetanus antitoxin.
    Corrêa A; Tavares J
    Rev Inst Med Trop Sao Paulo; 1967; 9(5):309-12. PubMed ID: 5618219
    [No Abstract]   [Full Text] [Related]  

  • 29. Quantification of tetanus antitoxin by toxin neutralization test in mice. A comparison between lethal and paralytic techniques.
    Christiansen G
    J Biol Stand; 1981 Oct; 9(4):453-60. PubMed ID: 7320026
    [No Abstract]   [Full Text] [Related]  

  • 30. The titration of tetanus antitoxin IV. Studies on the sensitivity and reproducibility of the toxin neutralization test.
    Gupta RK; Maheshwari SC; Singh H
    J Biol Stand; 1985 Apr; 13(2):143-9. PubMed ID: 3997896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Tetanus prophylaxis using purified hyperimmune sera. 1. Study of proteolysed equine antitoxin catabolism in laboratory animals].
    Depelchin A
    Ann Inst Pasteur (Paris); 1972 Nov; 123(5):681-94. PubMed ID: 4573184
    [No Abstract]   [Full Text] [Related]  

  • 32. The toxin binding inhibition test as a reliable in vitro alternative to the toxin neutralization test in mice for the estimation of tetanus antitoxin in human sera.
    Hendriksen CF; vd Gun JW; Nagel J; Kreeftenberg JG
    J Biol Stand; 1988 Oct; 16(4):287-97. PubMed ID: 3198659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of an ELISA for measuring the activity of tetanus toxoid in vaccines and comparison with the toxin neutralization test in mice.
    Manghi MA; Pasetti MF; Brero ML; Deluchi S; di Paola G; Mathet V; Eriksson PV
    J Immunol Methods; 1994 Jan; 168(1):17-24. PubMed ID: 8288891
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tetanus antibody assay combining in-house ELISA and particle agglutination test and its serosurvey application in a province in Turkey.
    Coplu N; Esen B; Gozalan A; Miyamura K; Yoshida I; Kurtoglu D; Dogan NO; Afacan G; Unal A; Ishida S; Takahashi M
    Jpn J Infect Dis; 2004 Jun; 57(3):97-102. PubMed ID: 15218217
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Tetanus antibodies in conventional gamma globulin preparations].
    Frühwein N
    Fortschr Med; 1979 Jun; 97(23):1063-4. PubMed ID: 88401
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunity against diphtheria and tetanus in German blood donors.
    Aue A; Hennig H; Krüger S; Closius B; Kirchner H; Seyfarth M
    Med Microbiol Immunol; 2003 May; 192(2):93-7. PubMed ID: 12736822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tetanus antitoxin potency assessment by surface plasmon resonance and ToBI test.
    Quintilio W; Kapronezai J; Takata DY; Marcelino JR; Moro AM
    Biologicals; 2019 Nov; 62():107-110. PubMed ID: 31519539
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparative data on the results of titrating tetanus antitoxin].
    Stovbun SF; Bukova VE; Shvarts SA
    Lab Delo; 1987; (7):547-50. PubMed ID: 2442492
    [No Abstract]   [Full Text] [Related]  

  • 39. Determination of tetanus antitoxin levels in hyperimmunized volunteers.
    Rubin ME; Sayed HI; Bowman JM
    Vox Sang; 1980; 38(1):6-11. PubMed ID: 6769245
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Determination of tetanus antitoxin levels in human immunoglobulins for intravenous use and in tetanus immunoglobulins by enzyme linked immunosorbent assay.
    Mainka C; Haase M
    ALTEX; 1995; 12(1):24-30. PubMed ID: 11178413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.